Australia, Nov. 25 -- CSL Behring Gene Therapy Inc., owns the trademark (2455984) for 'CYTEGRITY' till Feb. 13, 2034.
Status: protected:
Registered/protected
Classes: 1 [Cell lines for scientific and research use; Cells for scientific, laboratory or medical research; Biological preparations, namely, viral vectors and gene vectors for scientific, laboratory or medical research; Cell lines; cell lines for gene expression, and for synthesis of biological compounds; cells for gene expression and for synthesis of biological compounds; viral vectors.] and 5 [Cell lines for medical purposes; Cells for medical or clinical use; Biological preparations, namely, viral vectors and gene therapy vectors for medical or clinical use for treating cancer, ...